Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-? Concentrations and Cognition Outcomes in?Alzheimer's Disease Patients: A?Multicenter, Randomized, Controlled Clinical Trial.
Boada M, Anaya F, Ortiz P, Olazar?n J, Shua-Haim JR, Obisesan TO, Hern?ndez I, Mu?oz J, Buendia M, Alegret M, Lafuente A, T?rraga L, N??ez L, Torres M, Grifols JR, Ferrer I, Lopez OL, P?ez A. Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-? Concentrations and Cognition Outcomes in?Alzheimer's Disease Patients: A?Multicenter, Randomized, Controlled Clinical Trial. J Alzheimers Dis. 2017; 56(1):129-143.